AVDL
AVDL
NASDAQ · Pharmaceuticals

Avadel Pharmaceuticals

$21.64
+0.01 (+0.05%)
As of May 2, 1:28 AM ET ·
Analyst Consensus
Hold
16
Analysts
High
Coverage
Buy 6 38%
Hold 10 63%
Sell 0 0%
Price Target
Analyst Price Target +437.3% upside
Low Target $84.09
Average Target $116.27
High Target $133.85
Current Price $21.64
Current
$21.64
Target
$116.27
$84.09 $116.27 avg $133.85
Scenario Analysis
Bear Case
$84.09
288.6%
Low target
Base Case
$116.27
+437.3%
Avg target
Bull Case
$133.85
+518.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$23.57
-8.2% from high
52-Week Low
$8.44
+156.6% from low
50-Day SMA
$21.51
+0.6% vs SMA
200-Day SMA
$15.56
+39.1% vs SMA
RSI (14)
61.3
Neutral
Target vs 52W High
$116.27
+393.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%